For more information or confidential assistance
se habla español

Alabama Mother Files Zofran Lawsuit

An Alabama mother and her nine-year-old son have filed a Zofran lawsuit. The mother’s doctor ordered her to begin taking the drug while she was pregnant, in January 2006, to combat nausea. The baby was born on August 12, 2006 and shortly after, doctors discovered he had a high, narrow... Read more »

Zofran Lawsuit Filed in Montana District Court

In a recent complaint against Zofran manufacturer GlaxoSmithKline (GSK), two Montana parents have alleged significant failures by GSK to properly warn women of the allegedly known risks of congenital birth defects in babies exposed to the drug in utero. The complaint includes the full history of the testing and approval of... Read more »

New Study Explores Transplacental Transfer of Zofran

A recent study published in the medical journal Clinical Pharmacology & Therapeutics evaluated the possibility that the anti-nausea drug, Zofran (ondansetron) might be used to treat neonatal abstinence syndrome. In doing so, the researchers also assessed the possible transfer of the drug from mother to fetus via the placenta. Zofran... Read more »

New Study Reveals Testosterone Drug Risk

Recent studies have provided conflicting and controversial results regarding testosterone drug risk to patients undergoing testosterone replacement therapy. However, a new report titled “Testosterone Therapy and Risk of Myocardial Infarction: A Pharmacoepidemiologic Study” published on January 13, found statistically significant results. Researchers Mahyar Etminan, Sean C. Skeldon, Sheldon Larry Goldenberg,... Read more »

33 Yaz Lawsuits Headed to Trial

U.S. District Judge David R. Herndon ─ who is overseeing all federal Yaz and Yasmin lawsuits ─ has identified 33 cases for early bellwether trials that will likely beginning during the middle of 2015. All product liability lawsuits regarding the birth control pills have been joined together under multidistrict litigation... Read more »

MDL Judge Reduces $9 Billion Actos Lawsuit Award

Japan-based pharmaceutical giant Takeda currently faces more than 8,000 Actos lawsuits that accuse the company of concealing bladder cancer risks. Most of these complaints have been coordinated in Louisiana federal court, as a part of multidistrict litigation, where a landmark Actos lawsuit award was rendered in the case of Terrence... Read more »